BRAND PRESCRIBING IS REQUIRED

BRAND PRESCRIBING IS REQUIRED

BRAND PRESCRIBING IS REQUIRED

ADDITIONAL NOTES FOR FORMULARY DESIGNATION

Nifedipine can be initiated from primary care. For some indications, such as vascular disease, myocardal infarction and hypertension, it can be initiated in primary care following recommendation from hospital clinician and clinical letter.

Prescribe by brand

• Difference in bioavailability between brands
• Please click here for further information

ADDITIONAL NOTES FOR FORMULARY DESIGNATION

Nifedipine can be initiated from primary care. For some indications, such as vascular disease, myocardal infarction and hypertension, it can be initiated in primary care following recommendation from hospital clinician and clinical letter.

Prescribe by brand

• Difference in bioavailability between brands
• Please click here for further information

ADDITIONAL NOTES FOR FORMULARY DESIGNATION

Nifedipine can be initiated from primary care. For some indications, such as vascular disease, myocardal infarction and hypertension, it can be initiated in primary care following recommendation from hospital clinician and clinical letter.

Prescribe by brand

• Difference in bioavailability between brands
• Please click here for further information

ADDITIONAL NOTES FOR FORMULARY DESIGNATION

Nifedipine can be initiated from primary care. For some indications, such as vascular disease, myocardal infarction and hypertension, it can be initiated in primary care following recommendation from hospital clinician and clinical letter.

Prescribe by brand

• Difference in bioavailability between brands
• Please click here for further information

BRAND PRESCRIBING IS REQUIRED

ADDITIONAL NOTES FOR FORMULARY DESIGNATION

Nifedipine can be initiated from primary care. For some indications, such as vascular disease, myocardal infarction and hypertension, it can be initiated in primary care following recommendation from hospital clinician and clinical letter.

Prescribe by brand

• Difference in bioavailability between brands
• Please click here for further information

BRAND PRESCRIBING IS REQUIRED

ADDITIONAL NOTES FOR FORMULARY DESIGNATION

Nifedipine can be initiated from primary care. For some indications, such as vascular disease, myocardal infarction and hypertension, it can be initiated in primary care following recommendation from hospital clinician and clinical letter.

Prescribe by brand

• Difference in bioavailability between brands
• Please click here for further information

BRAND PRESCRIBING IS REQUIRED

ADDITIONAL NOTES FOR FORMULARY DESIGNATION

Nifedipine can be initiated from primary care. For some indications, such as vascular disease, myocardal infarction and hypertension, it can be initiated in primary care following recommendation from hospital clinician and clinical letter.

Prescribe by brand

• Difference in bioavailability between brands
• Please click here for further information

BRAND PRESCRIBING IS REQUIRED

ADDITIONAL NOTES FOR FORMULARY DESIGNATION

Nifedipine can be initiated from primary care. For some indications, such as vascular disease, myocardal infarction and hypertension, it can be initiated in primary care following recommendation from hospital clinician and clinical letter.

Prescribe by brand

• Difference in bioavailability between brands
• Please click here for further information

BRAND PRESCRIBING IS REQUIRED

ADDITIONAL NOTES FOR FORMULARY DESIGNATION

Nifedipine can be initiated from primary care. For some indications, such as vascular disease, myocardal infarction and hypertension, it can be initiated in primary care following recommendation from hospital clinician and clinical letter.

Prescribe by brand

• Difference in bioavailability between brands
• Please click here for further information

BRAND PRESCRIBING IS REQUIRED

ADDITIONAL NOTES FOR FORMULARY DESIGNATION

Nifedipine can be initiated from primary care. For some indications, such as vascular disease, myocardal infarction and hypertension, it can be initiated in primary care following recommendation from hospital clinician and clinical letter.

Prescribe by brand

• Difference in bioavailability between brands
• Please click here for further information

BRAND PRESCRIBING IS REQUIRED

ADDITIONAL NOTES FOR FORMULARY DESIGNATION

Nifedipine can be initiated from primary care. For some indications, such as vascular disease, myocardal infarction and hypertension, it can be initiated in primary care following recommendation from hospital clinician and clinical letter.

Prescribe by brand

• Difference in bioavailability between brands
• Please click here for further information

BRAND PRESCRIBING IS REQUIRED

ADDITIONAL NOTES FOR FORMULARY DESIGNATION

Nifedipine can be initiated from primary care. For some indications, such as vascular disease, myocardal infarction and hypertension, it can be initiated in primary care following recommendation from hospital clinician and clinical letter.

Prescribe by brand

• Difference in bioavailability between brands
• Please click here for further information

BRAND PRESCRIBING IS REQUIRED

NHS England Guidance (Dec-17):

• Do not initiate prolonged-release formulation for any new patients
• Deprescribing/switching of all patients to immediate release doxazosin supported - similar benefit, lower cost, also used once-daily
• See UKMI ref for switching advice

Resource: Patient leaflet explaining NHS Changes to Doxazosin Prescribing

NHS England Guidance (Dec-17):

• Do not initiate prolonged-release formulation for any new patients
• Deprescribing/switching of all patients to immediate release doxazosin supported - similar benefit, lower cost, also used once-daily
• See UKMI ref for switching advice

Resource: Patient leaflet explaining NHS Changes to Doxazosin Prescribing

NHS England Guidance (Dec-17):

• Do not initiate prolonged-release formulation for any new patients
• Deprescribing/switching of all patients to immediate release doxazosin supported - similar benefit, lower cost, also used once-daily
• See UKMI ref for switching advice

Resource: Patient leaflet explaining NHS Changes to Doxazosin Prescribing

NHS England Guidance (Dec-17):

• Do not initiate prolonged-release formulation for any new patients
• Deprescribing/switching of all patients to immediate release doxazosin supported - similar benefit, lower cost, also used once-daily
• See UKMI ref for switching advice

Resource: Patient leaflet explaining NHS Changes to Doxazosin Prescribing

ADDITIONAL NOTES FOR FORMULARY DESIGNATION

Nifedipine can be initiated from primary care. For some indications, such as vascular disease, myocardal infarction and hypertension, it can be initiated in primary care following recommendation from hospital clinician and clinical letter.

Prescribe by brand

• Difference in bioavailability between brands
• Please click here for further information

ADDITIONAL NOTES FOR FORMULARY DESIGNATION

Nifedipine can be initiated from primary care. For some indications, such as vascular disease, myocardal infarction and hypertension, it can be initiated in primary care following recommendation from hospital clinician and clinical letter.

Prescribe by brand

• Difference in bioavailability between brands
• Please click here for further information

ADDITIONAL NOTES FOR FORMULARY DESIGNATION

Nifedipine can be initiated from primary care. For some indications, such as vascular disease, myocardal infarction and hypertension, it can be initiated in primary care following recommendation from hospital clinician and clinical letter.

Prescribe by brand

• Difference in bioavailability between brands
• Please click here for further information

ADDITIONAL NOTES FOR FORMULARY DESIGNATION

Nifedipine can be initiated from primary care. For some indications, such as vascular disease, myocardal infarction and hypertension, it can be initiated in primary care following recommendation from hospital clinician and clinical letter.

Prescribe by brand

• Difference in bioavailability between brands
• Please click here for further information

ADDITIONAL NOTES FOR FORMULARY DESIGNATION

Nifedipine can be initiated from primary care. For some indications, such as vascular disease, myocardal infarction and hypertension, it can be initiated in primary care following recommendation from hospital clinician and clinical letter.

Prescribe by brand

• Difference in bioavailability between brands
• Please click here for further information

ADDITIONAL NOTES FOR FORMULARY DESIGNATION

Nifedipine can be initiated from primary care. For some indications, such as vascular disease, myocardal infarction and hypertension, it can be initiated in primary care following recommendation from hospital clinician and clinical letter.

Prescribe by brand

• Difference in bioavailability between brands
• Please click here for further information

ADDITIONAL NOTES FOR FORMULARY DESIGNATION

Nifedipine can be initiated from primary care. For some indications, such as vascular disease, myocardal infarction and hypertension, it can be initiated in primary care following recommendation from hospital clinician and clinical letter.

Prescribe by brand

• Difference in bioavailability between brands
• Please click here for further information

ADDITIONAL NOTES FOR FORMULARY DESIGNATION

Nifedipine can be initiated from primary care. For some indications, such as vascular disease, myocardal infarction and hypertension, it can be initiated in primary care following recommendation from hospital clinician and clinical letter.

Prescribe by brand

• Difference in bioavailability between brands
• Please click here for further information

ADDITIONAL NOTES FOR FORMULARY DESIGNATION

Nifedipine can be initiated from primary care. For some indications, such as vascular disease, myocardal infarction and hypertension, it can be initiated in primary care following recommendation from hospital clinician and clinical letter.

Prescribe by brand

• Difference in bioavailability between brands
• Please click here for further information

BRAND PRESCRIBING IS REQUIRED

BRAND PRESCRIBING IS REQUIRED

BRAND PRESCRIBING IS REQUIRED

ADDITIONAL NOTES FOR FORMULARY DESIGNATION

Nifedipine can be initiated from primary care. For some indications, such as vascular disease, myocardal infarction and hypertension, it can be initiated in primary care following recommendation from hospital clinician and clinical letter.

Prescribe by brand

• Difference in bioavailability between brands
• Please click here for further information

If it is for the specific condition you are asked to continue treatment for and you are happy to prescribe in accordance with the guideline, then take over the agreed responsibilities including prescribing. Please ensure the document is scanned into the patient's electronic records.

Click here for the Shared Care Guideline Repository


If sufficient information has not been provided and if you do not feel happy to continue to prescribe, it is advisable to refer the patient back to the specialist clinic and complete and send as soon as possible an 'inappropriate prescribing request communication form' .
 

LIPID MANAGEMENT PATHWAY WILL BE REVIEWED ACROSS NORTH EAST LONDON CCG TO INFORM THE PLACE OF THERAPY OF INCLISIRAN WITH OTHER LIPID-LOWERING AGENTS. AS THIS IS NICE APPROVED FOR USE IN PRIMARY CARE, FORMULARY DESIGNATION IS GREEN. IT IS ADVISABLE TO SEEK SPECIALIST INPUT IF CONSIDERING PRESCRIBING IN PRIMARY CARE FOR A PATIENT THAT MEETS THE NICE CRITERIA

FURTHER INFORMATION ON LIPID MANAGEMENT PATHWAY WILL FOLLOW. 

Inclisiran is recommended as an option for treating primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia as an adjunct to diet in adults. It is recommended only if:

• there is a history of any of the following cardiovascular events:
• • acute coronary syndrome (such as myocardial infarction or unstable angina needing hospitalisation)
  • coronary or other arterial revascularisation procedures
  • coronary heart disease
  • ischaemic stroke or
  • peripheral arterial disease, and
• low-density lipoprotein cholesterol (LDL-C) concentrations are persistently 2.6 mmol/l or more, despite maximum tolerated lipid-lowering therapy, that is:
• • maximum tolerated statins with or without other lipid-lowering therapies or,
  • other lipid-lowering therapies when statins are not tolerated or are contraindicated

Further information on NICE TA733: https://www.nice.org.uk/guidance/TA733

BRAND PRESCRIBING IS REQUIRED

BRAND PRESCRIBING IS REQUIRED

BRAND PRESCRIBING IS REQUIRED

BRAND PRESCRIBING IS REQUIRED

BRAND PRESCRIBING IS REQUIRED

BRAND PRESCRIBING IS REQUIRED

BRAND PRESCRIBING IS REQUIRED

BRAND PRESCRIBING IS REQUIRED

BRAND PRESCRIBING IS REQUIRED

ADDITIONAL NOTES FOR FORMULARY DESIGNATION

Nifedipine can be initiated from primary care. For some indications, such as vascular disease, myocardal infarction and hypertension, it can be initiated in primary care following recommendation from hospital clinician and clinical letter.

Prescribe by brand

• Difference in bioavailability between brands
• Please click here for further information

BRAND PRESCRIBING IS REQUIRED

BRAND PRESCRIBING IS REQUIRED

BRAND PRESCRIBING IS REQUIRED

If it is for the specific condition you are asked to continue treatment for and you are happy to prescribe in accordance with the guideline, then take over the agreed responsibilities including prescribing. Please ensure the document is scanned into the patient's electronic records.

Click here for the Shared Care Guideline Repository


If sufficient information has not been provided and if you do not feel happy to continue to prescribe, it is advisable to refer the patient back to the specialist clinic and complete and send as soon as possible an 'inappropriate prescribing request communication form' .